Cargando…

Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients

BACKGROUND: IFNβs are known as one of the most promising drugs used for COVID-19 treatment. This study aimed to investigate the effects of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) on COVID-19 inpatients. METHODS: In this study, we retrospectively evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyfi, Shahram, Latifi, Kayvan, Amri male, Parviz, Sadeghi Haddad Zavareh, Mahmoud, Ezoji, Khadijeh, Mohammadnia-Afrozi, Mousa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516800/ https://www.ncbi.nlm.nih.gov/pubmed/34688151 http://dx.doi.org/10.1016/j.intimp.2021.108241

Ejemplares similares

Overexpression of Recombinant Human Beta Interferon (rhINF-β) in Periplasmic Space of Escherichia coli
por: Morowvat, Mohammad Hossein, et al.
Publicado: (2014)

Interferon beta-1b for COVID-19
por: Shalhoub, Sarah
Publicado: (2020)

Pregnancy outcomes in patients exposed to interferon beta-1b
por: Romero, Rebecca S, et al.
Publicado: (2015)

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
por: Weller, Ivonne, et al.
Publicado: (2015)

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue
por: Dubey, S., et al.
Publicado: (2020)

Overexpression of the recombinant human interferon-beta (rhIFN-β) gene in tobacco chloroplasts
por: Feizi, Asghar, et al.
Publicado: (2021)

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis
por: Marziniak, Martin, et al.
Publicado: (2014)

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Paolicelli, Damiano, et al.
Publicado: (2009)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Jankovic, Slobodan M
Publicado: (2010)

Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy
por: Zettl, Uwe Klaus, et al.
Publicado: (2016)

Interferon beta-1a–induced morphea
por: Bezalel, Spencer A., et al.
Publicado: (2014)

Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis
por: Rajendran, Ranjithkumar, et al.
Publicado: (2022)

Deep morphea induced by interferon-β1b injection
por: Lee, Erika Yue, et al.
Publicado: (2016)

Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety Study
por: Jacques, F., et al.
Publicado: (2012)

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b
por: Hartung, Hans-Peter, et al.
Publicado: (2015)

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses
por: Hwang, Mihyun, et al.
Publicado: (2018)

Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway
por: Wang, Qin, et al.
Publicado: (2015)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma
por: Liu, Yu, et al.
Publicado: (2020)

Efficacy of Fish Oil on Serum of TNFα, IL-1β, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b
por: Ramirez-Ramirez, V., et al.
Publicado: (2013)

Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer’s disease
por: Mudò, Giuseppa, et al.
Publicado: (2019)

Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a
por: Lim, Ee Tuan, et al.
Publicado: (2004)

Alternative statistical methods for estimating efficacy of interferon beta-1b for multiple sclerosis clinical trials
por: Mieno, Makiko N, et al.
Publicado: (2011)

SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology
por: Kamm, Christian P, et al.
Publicado: (2009)

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
por: Croze, E, et al.
Publicado: (2013)

Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
por: Gobbi, Claudio, et al.
Publicado: (2013)

Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China
por: Xu, Yan, et al.
Publicado: (2019)

The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies
por: Hartung, Hans-Peter, et al.
Publicado: (2012)

Interferon-β1b Increases Th2 Response in Neuromyelitis Optica
por: Nakajima, Hideto, et al.
Publicado: (2012)

The effects of interferon-β (IFN-β) treatment on synovial cytokine expression in collagen induced arthritis in DBA/1 mice
por: van Holten, J, et al.
Publicado: (2002)

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
Publicado: (1987)

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT(®) Autoinjector: A Retrospective Cohort Study
por: Butler, Oisín, et al.
Publicado: (2021)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
por: Reuss, Reinhard
Publicado: (2013)

HSPD1 Interacts with IRF3 to Facilitate Interferon-Beta Induction
por: Lin, Lan, et al.
Publicado: (2014)

Effects of Systemic and Local Interferon Beta-1a on Epidural Fibrosis
por: Taşkapılıoğlu, Mevlüt Özgür, et al.
Publicado: (2016)

Interferon-beta-1a/natalizumab: Lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22g1i8nt82bknvdv8rskqou5j0